Orion sues Wockhardt Over Parkinson's Drug

Law360, New York (September 14, 2007, 12:00 AM EDT) -- In a bid to stave off generic competition for the Parkinson's disease treatment Comtan, the Finnish drugmaker Orion has filed a U.S. patent infringement suit against Indian pharmaceutical company Wockhardt Ltd. and a U.S. subsidiary.

Orion announced that it filed the suit late Thursday, over the defendants' efforts to obtain regulatory approval for generic 200 milligram entacapone tablets. Entacapone is the active ingredient in Comtan, which is marketed in the U.S. by Novartis.

“Orion Corporation and Novartis will vigorously defend the intellectual property rights covering Comtan,”...
To view the full article, register now.